AbbVie and Iambic Announce Collaboration to Accelerate AI-driven Drug Discovery
Iambic official newsroom · 行业原文收录 · 来源发布：Mon Sep 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · 本站收录：Thu Oct 08 2026 09:08:23 GMT+0000 (Coordinated Universal Time)
已保存的原文节选
− Multi-year partnership applies Iambic’s AI platform to speed up small molecule drug discovery in immunology, neuroscience and oncology − Companies to pursue programs with both first-in-class and best-in-class potential, combining Iambic’s molecular superintelligence platform with AbbVie’s therapeutic area expertise NORTH CHICAGO, Ill., and SAN DIEGO, Sept. 21, 2026 – AbbVie (NYSE: ABBV) and Iamb
以上为带出处的原文节选，完整内容请阅读原始链接。自动收录与主题分类不等于事实核验。